Effects of Black Soy Peptide Supplementation on Blood Pressure

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT01674491

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose basic science
Phase
Phase 3
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01674491
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01674491. Randomized; quadruple masking; primary purpose basic science. Start 2011-07 (registry gives no type); primary completion 2011-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Black Soy Peptide Supplementation on Blood Pressure
Condition
Hypertension
Intervention (Dietary supplement)
black soy peptide
Lead sponsor
Yonsei University (class: other)

Record details

Record id
cardio:ct-nct01674491
Content hash
cf27330549d1e2b0a9b7a2b411f8344117b7f18c0f1369ce6361a8911a97f7ac